Tamás László

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 15, 2025
Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy.

Tamás László, László Imre Pinczés, Bence Bátai

|Nov 21, 2023
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Tamás László, Lili Kotmayer, Viktória Fésüs

|Mar 29, 2023
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.

Lili Kotmayer, Tamás László, Gábor Mikala

Pageof 1